Business Context and Reporting Period
This Form 8-K is filed by Tharimmune, Inc. (THAR) on November 10, 2023. The filing addresses a notice received from The Nasdaq Stock Market LLC regarding the Company's failure to meet continued listing requirements. The Company is incorporated in Delaware and trades on The Nasdaq Capital Market.
Key Financial Metrics
The filing references specific financial data from the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2023:
- Stockholders' Equity: $1,756,923
- Nasdaq Minimum Requirement: $2,500,000
- Alternative Standards Met: No (Market value of listed securities below $35 million; net income from continuing operations below $500,000 for the required periods).
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity beyond the stockholders' equity figure.
Material Changes and Listing Status
The Company is currently non-compliant with Nasdaq Listing Rule 5550(b)(1) due to insufficient stockholders' equity. While the stock continues to trade under the symbol "THAR," the Company faces potential delisting if compliance is not restored. The filing does not detail operational changes or revenue fluctuations compared to prior periods.
Outlook, Risks, and Management Commentary
Compliance Timeline: The Company has 45 calendar days (until December 26, 2023) to submit a plan to regain compliance. If accepted, an extension of up to 180 days may be granted to evidence compliance.
Management Actions: The Company is actively seeking financing options to meet the equity requirement and expects to develop a compliance plan for submission to Nasdaq.
Risks and Contingencies: There is no assurance that a compliance plan will be developed, accepted by Nasdaq, or that the Company will ultimately regain compliance. If a plan is rejected, the Company may appeal to a Nasdaq Hearings Panel.
Investor Verification Checklist
- Verify the Company's ability to secure financing before the December 26, 2023 deadline.
- Monitor the submission and acceptance status of the compliance plan with Nasdaq.
- Review the most recent Form 10-Q for detailed revenue, cash flow, and debt metrics not included in this 8-K.
- Assess the risk of delisting if the Company fails to meet the $2.5 million equity threshold or alternative standards.